Zynaxis Inc. of Malvern, Pa., announced Monday that it has beenawarded a Small Business Innovative Research (SBIR) Grantfrom the National Heart, Lung and Blood Institute. The $50,000Phase I grant will be used to develop a diagnostic test systemto directly measure low-density lipoprotein (LDL)concentrations in human serum.

(c) 1997 American Health Consultants. All rights reserved.